This document is a USPTO patent application (US20260083740A1) for a method of treating Parkinson's Disease by administering escalating doses of tavapadon. The application was filed on September 23, 2025, and lists Sridhar Duvvuri as the inventor. The CPC classifications indicate relevance to pharmaceutical compositions and treatments for nervous system disorders.

As this is a patent application, it does not impose immediate regulatory obligations on pharmaceutical companies or healthcare providers. However, it signifies potential future intellectual property and market exclusivity for tavapadon in Parkinson's Disease treatment, which may influence R&D strategies and competitive landscapes.